Table A2.
Exposures Included in the Model by Tumor Type | Analysis |
||
---|---|---|---|
Deviance | df | LRT P | |
Meningioma | |||
Null model | 127.54 | 92 | |
Radiation linear in continuous dose | 50.83 | 91 | < .001* |
Plus quadratic in continuous dose | 50.82 | 90 | .954† |
Plus cubic in continuous dose | 50.72 | 89 | .748† |
Plus quartic in continuous dose | 50.47 | 88 | .618† |
Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose | 44.87 | 90 | .015† |
Plus quadratic in continuous dose of intrathecal methotrexate | 43.67 | 89 | .274‡ |
Plus cubic in continuous dose of intrathecal methotrexate | 35.48 | 88 | .004‡ |
Plus quartic in continuous dose of intrathecal methotrexate | 35.48 | 87 | .931‡ |
Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose + modification by genetic susceptibility | 44.78 | 89 | .780‡ |
Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose + interaction | 44.69 | 89 | .676‡ |
Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose + modification by age at exposure | 44.57 | 89 | .583‡ |
Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose + modification by time since exposure | 44.19 | 89 | .539‡ |
Radiation linear in continuous dose + intrathecal methotrexate linear in continuous dose + first primary cancer group | 35.02 | 81 | .362‡ |
Glioma/PNET | |||
Null model | 81.79 | 59 | |
Radiation linear in continuous dose | 69.58 | 58 | < .001* |
Plus quadratic in continuous dose | 67.12 | 57 | .117† |
Plus cubic in continuous dose | 65.45 | 56 | .197† |
Plus quartic in continuous dose | 64.64 | 55 | .367† |
Radiation linear in continuous dose + modification by genetic susceptibility | 63.77 | 57 | .016† |
Radiation linear in continuous dose + modification by age at exposure | 65.05 | 57 | .033† |
Radiation linear in continuous dose + modification by time since exposure | 68.74 | 57 | .359† |
NOTE. Radiation dosed in Gy; chemotherapeutic drugs dosed in milligrams per meter squared.
Abbreviations: df, degrees of freedom; LRT, likelihood ratio test; PNET, primitive neuroectodermal tumor.
LRT P value relative to null model.
LRT P value relative to model with radiation fitted as a linear trend in continuous dose.
LRT P value relative to model with radiation and intrathecal methotrexate each fitted as a linear trend in continuous dose.